Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Federal advisory committees

This article was originally published in The Gray Sheet

Executive Summary

To be the focus of a July 14 hearing of the House Government Reform and Oversight/Government Management, Information and Technology Subcommittee. The Subcommittee will: examine two recent reports on the Federal Advisory Committee Act by the General Accounting Office, explore concerns related to the management and accountability of advisory committees; and consider whether FACA presents barriers to public participation. The meeting begins at 2:00 in Room 2154 of the Rayburn building

Latest Headlines
See All
UsernamePublicRestriction

Register

MT010331

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel